Abstract
In the state of Hawai‘i, Native Hawaiians and Filipinos suffer from increased disparities, compared to other groups, in diabetes prevalence and adverse health outcomes that are exacerbated by challenges to health care access among rural communities. To address the limited literature describing rural, underserved patients with diabetes in Hawai‘i, this paper aims to characterize two rural communities that are located on Moloka‘i and Lana‘i in federally-designated medically underserved areas and that are served by a single Native Hawaiian health care system entitled Na Pu‘uwai. Descriptive analyses examining associations between variables were performed using the baseline demographic information, clinical measures, and questionnaire responses collected from 40 adult study participants with diabetes. The data revealed that the study participants had a high prevalence of insulin use (60%); a HbA1c level greater than or equal to 9% (55%); a high-fat diet (73%); and comorbidities, including hyperlipidemia (85%), hypertension (83%), and obesity (70%). Furthermore, among the participants, the mean SF-12v2™ General Health Perceptions Score was significantly lower for participants with uncontrolled diabetes compared to those with controlled diabetes (P = .02); however, this association was not statistically significant in the multivariable regression model that adjusted for age and number of diabetes medications. Based on these results, the participants appear to belong to a high-risk group with a complicated manifestation of diabetes. This study adds to the growing body of literature demonstrating disparities in diabetes among rural, minority, and underserved communities, highlighting the need for further investigation, development, and implementation of strategies for reaching these vulnerable populations.
Keywords: Adult, Diabetes Mellitus, Type 2, Diabetes Epidemiology, Hawai‘i, Health Status Disparities, Healthcare Disparities, Minority Health, Rural Health
Introduction
Currently the fifth leading cause of death in Hawai‘i, diabetes represents a significant burden for the state's people, affecting 8.3% of the Hawai‘i adult population in 2010 and accounting for $1 billion in costs to the state in 2006.1–4 Among the five largest ethnic groups of Hawai‘i, diabetes disproportionately impacts Native Hawaiians and Filipinos. Compared to whites in Hawai‘i, Native Hawaiians and Filipinos not only are on average 5–8 years of age younger at the time of diabetes diagnosis, but also have a 3–4 fold higher prevalence of diabetes.2,5 Between 2004 and 2006, Native Hawaiians suffered from the highest rate of death from diabetes at 29.6 per 100,000, followed by 20.6 per 100,000 in Filipinos, 12.4 per 100,000 in Japanese, and 10.3 per 100,000 in Whites.2
The health disparities suffered by Native Hawaiians and Filipinos are further exacerbated when these racial/ethnic populations reside in rural communities, where health care access remains a challenge.6,7 In fact, one-third of Hawai‘i's state population resides in rural communities, in contrast to only 17% of the US population.8,9 Compared to Honolulu County, Hawai‘i's rural counties have more diabetic patients per medical specialist.6,10,11 Rural residents are particularly vulnerable to developing serious and deadly diabetes-related complications due to limited access to non-urgent preventive care that is known to ameliorate the development of diabetic microvascular and macrovascular complications; this type of care includes diabetes self-management education, retinal screening, and cardiovascular risk management.2 Ultimately, these challenges may result in a population that is less healthy overall and that may require higher tertiary care services at a higher cost to the health care system.7,12 While diabetes prevalence is comparable among the counties of Hawai‘i, issues in rural health could potentially explain the disparities in diabetes mortality rates by county. For example, in 2009, Maui County (includes the islands of Maui, Lana‘i, and Moloka‘i) and Kaua‘i County suffered from higher rates of death due to diabetes (33.0 per 100,000 and 34.1 per 100,000 respectively) than Honolulu County (21.9 per 100,000).1,2 To address issues related to diabetes medical management in rural Hawai‘i, we undertook a quasi-experimental pilot study to examine the effectiveness of using telemedicine technology to provide diabetes specialty care in two remote communities on Lana‘i and Moloka‘i islands. The pilot study, entitled Pūlama Pau ‘Ole I Ka Mimikō (Continually Taking Care of People with Diabetes), enrolled volunteers through the community-based organization, the Na Pu‘uwai Health Care System that services both Lana‘i and Moloka‘i islands.
Although diabetes prevalence rates in the rural communities of Hawai‘i have been reported in the literature, characterization of the diabetic patients living in these areas remains limited.5,13,14 A better understanding of the health status and needs of these patients would be valuable for tailoring diabetes interventions and treatments to more effectively care for the rural, underserved populations of Hawai‘i. To address this gap in knowledge, this paper aims to use patient baseline clinical measures and questionnaire responses to characterize a predominantly Native Hawaiian and Filipino, diabetic, and clinic-based population residing in two rural neighbor islands of Hawai‘i.
Methods
Study Design
This paper analyzes the baseline characteristics collected from participants who enrolled in the Pūlama Pau ‘Ole I Ka Mimikō study (aka, the Pūlama Study). The goal of this 6-month pilot study was to test a culturally competent chronic disease management program using telemedicine technologies (ie, video-teleconferencing) compared with usual care in type 2 diabetics. The Pūlama study was conducted on Moloka‘i and Lana‘i, which are two islands in federally-designated medically underserved areas with large numbers of Native Hawaiians and Filipinos.7 Both communities are served by the Na Pu‘uwai Native Hawaiian Health Care System. Patients were recruited at Na Pu‘uwai's Moloka‘i and Lana‘i clinical services programs, which routinely provide outpatient care services and community outreach health screenings in both rural communities. Recruitment was conducted via flyers, education outreach programs, and clinic staff. Approval was received from the University of Hawai‘i Institutional Review Board prior to the start of any research activities.
Eligibility and Enrollment
A total of 113 individuals were contacted and screened for eligibility. A total of 40 people with diabetes met all eligibility criteria and agreed to participate. To be eligible, participants had to be age 18 years or older, have a diagnosis of type 2 diabetes, have a Hemoglobin A1c (HbA1c) level of ≥ 7.5% in the month prior to enrollment, be taking at least one anti-diabetic medication, and be residing on Moloka‘i or Lana‘i. The enrollment cutoff point of HbA1c level of 7.5% or higher was selected to ensure that all potential participants who qualified to enroll would benefit from having an HbA1c of < 7%, the American Diabetes Association goal for HbA1c levels.15
Individuals were excluded if they had any major medical (eg, hemodialysis, pregnancy, etc.) or psychiatric disorders that would prevent full participation (ie, non-adherence due to conflicting medical recommendations or psychiatric problems) in the study as determined by the study protocol. After giving written informed consent, participants underwent a baseline assessment according to study protocol.
Data Collection
Demographic factors including date of birth, sex, education, marital status, ethnicity, and smoking status were collected via a patient questionnaire. At baseline, participants were assessed for height, weight, and blood pressure. The participant's HbA1c, fasting glucose, and lipid profile results were abstracted from laboratory tests, which were conducted within one month of study enrollment. Information on past medical history and medications were obtained with a questionnaire and/or from the participant's medical record.
Participants also completed a collection of surveys that were administered by the study nurse or self-administered. The 10-item short version of the Center for Epidemiologic Studies Depression Scale (CES-D) assessed self-reported depressive symptoms. Higher scores indicate more depressive symptoms and a score of 10 or greater signifies self-reported evidence of depression.16,17 The Short Form-12v2™ Health Survey (SF-12v2™) was administered to measure health-related quality of life, and the study focused on the General Health Perceptions sub-scale, which is based on a single question asking patients to rate their general health. The SF-12v2™ uses a norm-based scoring method based on the 1998 general US population having a mean of 50 ± 10, with higher scores indicating a better health-related quality of life.18 The proportion of fat intake in each participant's diet was determined using the Fat Factor Summary Score generated by the Eating Habits Questionnaire, which was adapted from the Eating and Exercise Patterns (EEPs) Questionnaire. Higher scores indicate greater fat intake and a Fat Factor Summary Score of greater than 2.5 predicts fat intake at greater than 30% of total calories.19 The participants' level of physical activity was assessed through an adapted version of the Brief Physical Activity Questionnaire, which addresses the frequency of the participants' vigorous and moderate intensity activities. The range of possible Physical Intensity Scores is 1 to 5 with lower scores indicating greater intensity.20 Finally, the Patient Assessment of Care for Chronic Conditions (PACIC) was used to evaluate how closely the participants' care aligned with the Chronic Care Model, which supports patient-centered and collaborative care. The PACIC produces a summary score based on sub-scales measuring patient activation, delivery system design and decision support, goal setting, problem-solving and contextual counseling, and follow-up and coordination. The PACIC Summary Score ranges from 1 to 5 with higher scores indicating a higher quality of care.21
Statistical Methods
Initial analyses examined the questionnaire responses and physiological measures descriptively. Continuous variables were summarized with means and standard deviations both for individual variables and within categories such as ethnic groups. Means of questionnaire responses comparing patients with controlled to uncontrolled diabetes were analyzed using t-tests. For the analyses, an HbA1c level of 9% or higher was chosen as an indicator of poor diabetes control, a cutoff employed in the National Committee on Quality Assurance's Healthcare Effectiveness Data and Information Set (HEDIS).22 Categorical variables were summarized using counts and percentages. Associations between categorical variables were examined using the Cochran-Mantel-Haenszel chi-square test for assessing group differences in outcomes having ordered categories, and using logistic regression. Exact logistic regression was employed when the number of outcomes within predictor categories was small. Results of the regression models are summarized as odds ratios with 95% confidence intervals.
Results
Participant Characteristics
A total of 40 diabetic patients (16 women and 24 men) with suboptimal glycemic control were enrolled with a mean age of 58 years and an age range of 24 to 88 years (Table 1). Most patients were married (80%) and had attended some college or had obtained a college degree (70%). About half had smoked in their lifetime. The majority identified ethnically as either Native Hawaiian (58%) or Filipino (25%). Nearly three-fourths of participants resided on the island of Moloka‘i and the remainder resided on the island of Lana‘i.
Table 1.
Demographic Characteristic | Pulama Study Participants n (%)a or Mean ± SD |
Age at enrollment (years) | 58 ± 13 |
Women | 16 (40) |
Marital status Married Not marriedb |
32 (80) 8 (20) |
Education High school or less Some college or college graduate |
12 (30) 28 (70) |
Race/Ethnicity Native Hawaiian Filipino Otherc |
23 (58) 10 (25) 7 (18) |
Residence Moloka‘i Lana‘i |
29 (73) 11 (28) |
Smoking status Never smoked Current or former smoker |
18 (45) 22 (55) |
Some percentages do not add up to 100% due to rounding
“Not married” includes never married, divorced or separated, and widowed
“Other” includes White (n = 4), Japanese (n = 2), and Samoan (n = 1)
Table 2 and Table 3 report the participants' mean baseline clinical measures and questionnaire results respectively. The majority of participants had a history of hypertension (83%) and hyperlipidemia (85%), and almost a third had a history of heart disease. About three-fourths were taking at least two diabetes medications and 60% were taking insulin (Table 2). Most participants (90%) had an SF-12v2™ General Health Perceptions score below the average score of the general US population, and 30% of participants scored below the average of those with diabetes within the general US population.18 Based on the CES-D and Eating Habits Questionnaire, 38% of the participants were depressed and nearly three-fourths had a diet with fat constituting over a third of their total caloric intake (Table 3).
Table 2.
Clinical Characteristic | Pulama Study Participants n (%) or Mean ± SD |
Clinical/Laboratory Assessments | |
Body mass index (kg/m2) Body mass index ≥ 30 |
33 ± 9 28 (70) |
Systolic blood pressure (mmHg) | 131 ± 20 |
Diastolic blood pressure (mmHg) | 76 ± 13 |
Hemoglobin A1c (%) Hemoglobin A1c ≥ 9% |
9.6 ± 1.6 22 (55) |
Fasting glucose (mg/dL) | 182 ± 62 |
Total cholesterol (mg/dL) | 167 ± 36 |
Triglycerides (mg/dL) | 207 ± 206 |
HDL-cholesterol (mg/dL) Women Men |
45 ± 10 42 ± 13 |
Calculated LDL-cholesterol (mg/dL) (n = 34)a | 87 ± 23 |
History of: | |
Hypertension | 33 (83) |
Hyperlipidemia | 34 (85) |
Gout | 5 (13) |
Heart disease | 12 (30) |
Diabetes Medications | |
Biguanide | 24 (60) |
Sulfonylurea | 26 (65) |
Thiazolidenedione | 7 (18) |
DPP4 Inhibitor | 12 (30) |
Insulin | 24 (60) |
Exenatide (Byetta) | 1 (3) |
Number of diabetes medications One Two Three Four |
9 (23) 14 (35) 11 (28) 6 (15) |
Unable to calculate LDL values for some participants (n = 6) due to their high levels of triglycerides.
Table 3.
Questionnaire | Pulama Study Participants n (%) or Mean ± SD |
Center for Epidemiologic Studies Depression Scale (CES-D) | |
CES-D Score Depressed |
7.6 ± 5.2 15 (38) |
SF-12v2™ Health Survey | |
General Health Perceptions Score Participants scoring below average of general US population (Score < 50) Participants scoring below average of US diabetic population (Score < 41) |
40 ± 11 36 (90) 12 (30) |
Eating Habits Questionnairea | |
Fat Factor Summary Score Fat Intake at > 30% of Total Calories |
2.7 ± 0.4 19 (73) |
Brief Physical Activity Questionnaire | |
Physical Intensity Score | 3.4 ± 1.1 |
Patient Assessment of Care for Chronic Conditions (PACIC) | |
PACIC Summary Score | 3.5 ± 0.9 |
For the Eating Habits Questionnaire, n = 26.
Factors Associated with Poor Glycemic Control
Fifty-five percent of the study participants had an HbA1c level of at least 9% (Table 2). Logistic regression analysis revealed that participants with controlled diabetes (HbA1c < 9%) did not differ significantly from participants with uncontrolled diabetes (HbA1c ≥ 9%) in terms of their age, sex, ethnicity, number of diabetes medications, number of comorbidities, or odds of having a SF-12v2™ General Health Perceptions Score below 50 (Table 4). However, the mean SF-12v2™ General Health Perceptions Score was 8 units lower for participants with uncontrolled diabetes compared to those with controlled diabetes (P = .02). When examined in a multivariable regression model, poor glycemic control was not significantly associated with increasing age, the number of diabetes medications, or a better health-related quality of life (Table 5).
Table 4.
Characteristic | Unadjusted Odds Ratio (95% CI) | P-value |
Age | ||
24–52 years | 1.0 Referent | |
53–64 years | 1.14 (.25–5.22) | .86 |
65–88 years | 1.00 (.21–4.67) | 1.00 |
Sex | ||
Women | 1.0 Referent | |
Men | .92 (.26–3.28) | .90 |
Ethnicity | ||
Other | 1.0 Referent | |
Native Hawaiian | 1.73 (.31–9.57) | .53 |
Filipino | 2.00 (.28–14.20) | .49 |
Number of diabetes medications | ||
1–2 | 1.0 Referent | |
≥ 3 | .87 (.25–3.05) | .82 |
Number of co-morbiditiesa | ||
0–2 | 1.0 Referent | |
≥ 3 | 3.17 (.66–15.11) | .15 |
SF-12v2™ Health Survey General Health Perceptions Score | ||
> 50 | 1.0 Referent | |
≥ 50 | 7.60 (1.2-Infinity) | .07 |
Comorbidities assessed in this study include only hypertension, hyperlipidemia, gout, and heart disease.
Table 5.
Adjusted Odds Ratioa | 95% Confidence Interval | |
Age | 1.01 | 0.95–1.07 |
Number of Diabetes Medications | 1.12 | 0.57–2.19 |
Better Health-Related Quality of Lifeb | 0.92 | 0.85–1.00 |
Age, number of diabetes medications, and better health-related quality of life were included in the model, and each was adjusted for the other two.
SF-12v2™ General Health Perceptions Score as a continuous variable.
Discussion
The predominantly Native Hawaiian and Filipino, rural, and clinic-based participants of the Pūlama study appeared to be less healthy than other diabetic patients surveyed nationally. Over half of the study participants suffered from uncontrolled diabetes. Poor glycemic control has also been observed in other rural communities in Hawai‘i. For example, a study conducted at the Waianae Coast Comprehensive Health Center (WCCHC) which serves a medically underserved, predominantly Native Hawaiian community on O‘ahu, also found more than 38% (n = 52) of their diabetic patients had poorly controlled diabetes (HbA1c >10%), while 25% of their patients were found to have a HbA1c of 7.5% or less.7,23 Compared to the general US diabetic population, the Pūlama study participants had a higher prevalence of insulin use, comorbidities (heart disease, hypertension, hyperlipidemia, and obesity), and fat intake exceeding the recommendations for a reduced fat diet, suggesting that this clinic-based population is at increased risk for adverse clinical outcomes such as microvascular and macrovascular complications.24–27 Additionally, nearly one-third of participants had an average rating for overall health that was lower than the average score of diabetic individuals who participated in the 1998 National Survey of Functional Health Status.18
Compared to participants with controlled diabetes, those with uncontrolled diabetes had a statistically significant lower mean SF-12v2™ Health Survey General Health Perceptions Score; however, this association was not statistically significant in the multivariable regression model that adjusted for age and number of diabetes medications. One study conducted with 150 patients seen at four diabetes clinics in Malaysia did find statistically significant differences between patients with controlled and poorly controlled diabetes in their mean General Health Perceptions Score after controlling for age and diabetes duration.28 However, this study differed from the Pūlama study in its use of the longer SF-36 Health Survey and less stringent criteria for poorly controlled diabetes. One possible explanation of the observed relationship between glycemic control and self-reported health status is that those with worse HbA1c values may suffer from greater complications and symptoms, and thus be more likely give a lower rating of their overall health. Nevertheless, the literature examining the relationship between glycemic control and health-related quality of life remains inconsistent.28–30 Furthermore, it is difficult to draw generalizable conclusions from the Pūlama study, since the data was obtained from a single time point as well as a small sample size, and there was a lack of control for confounders.
Other studies identifying predictors of glycemic control similarly have not found statistically significant differences between controlled and uncontrolled diabetic patients in terms of gender, history of hypertension, or history of dyslipidemia.31–35 Some predictors of higher HbA1c levels in diabetic patients that have been documented include increased waist circumference, poor adherence to diabetes self-care management behaviors, low income, lack of insurance, and increased distress about diabetes, none of which were examined in the Pūlama study.31,33,35 Moreover, medication type, diabetes duration, and age have been shown to be associated with poor glycemic control in some studies, although the evidence is contradictory.31–37 These studies used different cut-off points for uncontrolled diabetes (HbA1c ≥ 7%, ≥ 8%, > 9.2%), which may affect comparisons with the Pūlama study (HbA1c ≥ 9%).
Study Limitations
This paper is descriptive in nature and possesses multiple limitations in addition to those detailed above. Because of its small sample size (N = 40), this study has low statistical power and confidence intervals that may be difficult to interpret. Furthermore, conclusions from this study may not be generalizable to other rural communities in Hawai‘i, and because of the selection criteria, the study may not have captured all the variability that exists within the communities from which the participants were sampled. Because the data was collected from a single point in time, temporality and causal relationships cannot be established. The participants were also sampled from clinic-based populations associated with Na Pu‘uwai and by definition were required to have a HbA1c value of ≥ 7.5%, so they are more likely to be sicker and have more complicated diabetes management (ie, insulin-requiring diabetes) compared to the general diabetic population. While some information was obtained from patient medical records, most data was collected via participant self-report, which could have introduced recall bias or social desirability bias. The survey instrument used to measure fat intake (Eating Habits Questionnaire) was introduced late into the study, so the measure was only available for 65% of the participants, which may have impacted the results of that variable considering the small size of the study.
Implications
This paper describes some of the characteristics of diabetic patients living in two isolated, medically underserved regions of Hawai‘i. This clinic population represents a high-risk group of patients with complicated diabetes mellitus, as reflected by the high prevalence of insulin use, poor glycemic control, a high-fat diet, and co-existing morbidities. Though the study included a relatively small select group of patients, these results highlight the burden of poorly controlled diabetes in remote locations that often have limited access to specialty care to address multi-complex management needs of patients with diabetes. Patients in these remote locations with poorly controlled diabetes also tended to have lower ratings of their overall health with about one-third of participants scoring lower than diabetic individuals surveyed in the 1998 National Survey of Functional Health Status.
With a high prevalence of uncontrolled diabetes, Native Hawaiian and Filipino diabetic patients in these rural communities of Hawai‘i may potentially have increased vulnerability to complications, such as heart disease, stroke, vision loss, kidney disease, nervous system damage, and amputations.38 These health issues may be compounded when communities face problems of reduced access to health care resources. Analysis of the 2009 BRFSS revealed that compared to non-rural diabetic adults, rural diabetic adults, and especially non-Caucasian rural diabetic adults, were less likely to receive adequate diabetes care, which included engaging in self-management behaviors; receiving diabetes education; and having one cholesterol check-up, at least two HbA1c check-ups, at least two feet check-ups, and a dilated eye exam in the past 12 months.39
This study adds to the growing body of literature demonstrating disparities in the burden of diabetes in rural, minority, and underserved communities, highlighting the necessity for further investigation, development, and implementation of strategies for reaching these vulnerable populations.40–42 The results of this small descriptive study suggest that further research on the factors that could improve diabetes control and influence morbidity and mortality due to complications of diabetes in these high risk populations is needed. Research examining the issue of access to specialty care (endocrinology, ophthalmology, etc.) and other health providers (Certified Diabetes Educators, dieticians, etc.) could also identify opportunities to improve diabetes management within these communities. A component of the Pūlama study intervention includes the use of telemedicine technologies to provide enhanced diabetes management (including specialty care) to diabetic patients on the island of Moloka‘i, which is a potentially promising strategy for reaching these small, remote/rural communities with complex diabetes related health problems.40,43,44 Finally, due to the high prevalence of self-reported depression (38%) among the participants, developing interventions designed to integrate behavioral health programs that address depression within the diabetic patient community could benefit the rural Native Hawaiian and Filipino communities examined here.
Acknowledgments
We would like to thank Dr. Erin McMurtray, Dr. Haya Rubin, Dr. Jimmy Efird, Donna Gamiao, and Valerie Janikowski for their invaluable contribution to this study. We would also like to acknowledge support from the following grants: P20 MD00173-07S1, S21 MD000228, and U54 MD007584.
Conflict of Interest
None of the authors identify any conflict of interest.
References
- 1.Vital Statistics Report. 2009. [February 16, 2012]. http://hawaii.gov/health/statistics/vital-statistics/index.html/vr_09/death.pdf.
- 2.Pobutsky A, Balabis J, Nguyen D-H, Tottori C. Hawai‘i Diabetes Report 2010. Honolulu: Hawai‘i State Department of Health, Chronic Disease Management and Control Branch, Diabetes Prevention and Control Program; 2010. [Google Scholar]
- 3.Salvail FR, Nguyen D, Liang S. 2010 State of Hawaii By Demographic Characteristics Behavioral Risk Factor Surveillance System. 2010. [February 16, 2012]. http://hawaii.gov/health/statistics/brfss/brfss2010/demo10.html.
- 4.American Diabetes Association, author. The Estimated Prevalence and Cost of Diabetes in Hawaii. 2008. [February 15, 2012]. http://www.diabetesarchive.net/advocacy-and-legalresources/cost-of-diabetes-results.jsp?state=Hawaii&district=0&DistName=Hawaii+%28Entire+State%29.
- 5.Grandinetti A, Kaholokula JK, Theriault AG, Mor JM, Chang HK, Waslien C. Prevalence of diabetes and glucose intolerance in an ethnically diverse rural community of Hawaii. Ethn Dis. Spring. 2007;17(2):250–255. [PubMed] [Google Scholar]
- 6.Hawai‘i Primary Care Association, author. Hawai‘i Primary Care Directory: A Directory of Safety Net Health Services in Hawai‘i. 2006. [January 4, 2012]. http://www.hawaiipca.net/media/assets/PrimaryCareDirectory2006.pdf.
- 7.Hawai‘i State Department of Health, Family Services Division, author. State of Hawai‘i Primary Care Needs Assessment Data Book 2009. 2010. [May 14, 2012]. http://hawaii.gov/health/doc/pcna2009databook.pdf.
- 8.United States Department of Agriculture Economic Research Service, author. State Fact Sheets: Hawaii. 2011. [January 4, 2012]. http://www.ers.usda.gov/StateFacts/HI.htm.
- 9.United States Department of Agriculture Economic Research Service, author. State Fact Sheets: United States. 2011. [January 4, 2012]. http://www.ers.usda.gov/StateFacts/US.htm.
- 10.Hawai‘i Health Information Corporation, author. Health Trends in Hawai‘i: A Profile of the Health Care System. [December 22, 2011]. http://healthtrends.org/resources_conven_physicians.aspx.
- 11.State of Hawai‘i, Behavioral Risk Factor Surveillance System 2010. Have you ever been told by a doctor that you have diabetes? [December 22, 2011]. http://hawaii.gov/health/statistics/brfss/brfss2010/2010/geo10/diabete2.html.
- 12.Institute of Medicine, author. Quality Through Collaboration: The Future of Rural Health. 2005. [Google Scholar]
- 13.Grandinetti A, Chang HK, Mau MK, et al. Prevalence of glucose intolerance among Native Hawaiians in two rural communities. Native Hawaiian Health Research (NHHR) Project. Diabetes Care. 1998 Apr;21(4):549–554. doi: 10.2337/diacare.21.4.549. [DOI] [PubMed] [Google Scholar]
- 14.Kim HS, Park SY, Grandinetti A, Holck PS, Waslien C. Major dietary patterns, ethnicity, and prevalence of type 2 diabetes in rural Hawaii. Nutrition. 2008 Nov-Dec;24(11–12):1065–1072. doi: 10.1016/j.nut.2008.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.American Diabetes Association, author. Clinical Practice Recommendations: Executive Summary: Standards of Medical Care in Diabetes - 20. Diabetes Care. 2010;33:S4–S10. doi: 10.2337/dc12-s004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale) Am J Prev Med. 1994 Mar-Apr;10(2):77–84. [PubMed] [Google Scholar]
- 17.Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1:385–401. [Google Scholar]
- 18.Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. SF-12v2™: How to Score Version 2 of the SF-12® Health Survey. Lincoln, RI: QualityMetric Incorporated; 2002. [Google Scholar]
- 19.Glanz K, Kristal AR, Sorensen G, Palombo R, Heimendinger J, Probart C. Development and validation of measures of psychosocial factors influencing fat- and fiber-related dietary behavior. Prev Med. 1993 May;22(3):373–387. doi: 10.1006/pmed.1993.1031. [DOI] [PubMed] [Google Scholar]
- 20.Marshall AL, Smith BJ, Bauman AE, Kaur S. Reliability and validity of a brief physical activity assessment for use by family doctors. Br J Sports Med. 2005 May;39(5):294–297. doi: 10.1136/bjsm.2004.013771. discussion 294–297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC) Med Care. 2005 May;43(5):436–444. doi: 10.1097/01.mlr.0000160375.47920.8c. [DOI] [PubMed] [Google Scholar]
- 22.National Committee for Quality Assurance, author. National Quality Forum-Endorsed Measures. 2008. http://www.ncqa.org/HEDISQualityMeasurement.aspx.
- 23.Humphry J, Jameson LM, Beckham S. Overcoming social and cultural barriers to care for patients with diabetes. West J Med. 1997 Sep;167(3):138–144. [PMC free article] [PubMed] [Google Scholar]
- 24.Centers for Disease Control and Prevention, author. Diabetes Data and Trends. 2012. [March 15, 2012]. http://apps.nccd.cdc.gov/DDTSTRS/default.aspx.
- 25.Nelson KM, Reiber G, Boyko EJ. Diet and exercise among adults with type 2 diabetes: findings from the third national health and nutrition examination survey (NHANES III) Diabetes Care. 2002 Oct;25(10):1722–1728. doi: 10.2337/diacare.25.10.1722. [DOI] [PubMed] [Google Scholar]
- 26.Oza-Frank R, Cheng YJ, Narayan KM, Gregg EW. Trends in nutrient intake among adults with diabetes in the United States: 1988-2004. J Am Diet Assoc. 2009 Jul;109(7):1173–1178. doi: 10.1016/j.jada.2009.04.007. [DOI] [PubMed] [Google Scholar]
- 27.Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008 Jan;31 Suppl 1:S61–S78. doi: 10.2337/dc08-S061. [DOI] [PubMed] [Google Scholar]
- 28.M. KI, A.A. I, L. N, W.B WM. Type 2 diabetes mellitus patients with poor glycaemic control have lower quality of life scores as measured by the Short Form-36. Singapore Med J. 2010;51(2):157–162. [PubMed] [Google Scholar]
- 29.Tapp RJ, Dunstan DW, Phillips P, Tonkin A, Zimmet PZ, Shaw JE. Association between impaired glucose metabolism and quality of life: results from the Australian diabetes obesity and lifestyle study. Diabetes Res Clin Pract. 2006 Nov;74(2):154–161. doi: 10.1016/j.diabres.2006.03.012. [DOI] [PubMed] [Google Scholar]
- 30.Sundaram M, Kavookjian J, Patrick JH, Miller LA, Madhavan SS, Scott VG. Quality of life, health status and clinical outcomes in Type 2 diabetes patients. Qual Life Res. 2007 Mar;16(2):165–177. doi: 10.1007/s11136-006-9105-0. [DOI] [PubMed] [Google Scholar]
- 31.Ghazanfari Z, Niknami S, Ghofranipour F, Larijani B, Agha-Alinejad H, Montazeri A. Determinants of glycemic control in female diabetic patients: a study from Iran. Lipids Health Dis. 2010;9:83. doi: 10.1186/1476-511X-9-83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications. 2010 Mar-Apr;24(2):84–89. doi: 10.1016/j.jdiacomp.2008.12.008. [DOI] [PubMed] [Google Scholar]
- 33.Kollannoor-Samuel G, Chhabra J, Fernandez ML, et al. Determinants of fasting plasma glucose and glycosylated hemoglobin among low income Latinos with poorly controlled type 2 diabetes. J Immigr Minor Health. 2011 Oct;13(5):809–817. doi: 10.1007/s10903-010-9428-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hartz A, Kent S, James P, Xu Y, Kelly M, Daly J. Factors that influence improvement for patients with poorly controlled type 2 diabetes. Diabetes Res Clin Pract. 2006 Dec;74(3):227–232. doi: 10.1016/j.diabres.2006.03.023. [DOI] [PubMed] [Google Scholar]
- 35.Nichols GA, Hillier TA, Javor K, Brown JB. Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care. 2000 Mar;23(3):273–277. doi: 10.2337/diacare.23.3.273. [DOI] [PubMed] [Google Scholar]
- 36.Goudswaard AN, Stolk RP, Zuithoff P, Rutten GE. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care. Eur J Epidemiol. 2004;19(6):541–545. doi: 10.1023/b:ejep.0000032351.42772.e7. [DOI] [PubMed] [Google Scholar]
- 37.Chan WB, Chan JC, Chow CC, et al. Glycaemic control in type 2 diabetes: the impact of body weight, beta-cell function and patient education. Qjm. 2000 Mar;93(3):183–190. doi: 10.1093/qjmed/93.3.183. [DOI] [PubMed] [Google Scholar]
- 38.Center for Disease Control and Prevention, author. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Center for Disease Control and Prevention; 2011. [Google Scholar]
- 39.Lutfiyya MN, McCullough JE, Mitchell L, Dean LS, Lipsky MS. Adequacy of diabetes care for older U.S. rural adults: a cross-sectional population based study using 2009 BRFSS data. BMC Public Health. 2011;11:940. doi: 10.1186/1471-2458-11-940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Hale NL, Bennett KJ, Probst JC. Diabetes care and outcomes: disparities across rural America. J Community Health. 2010 Aug;35(4):365–374. doi: 10.1007/s10900-010-9259-0. [DOI] [PubMed] [Google Scholar]
- 41.Johnson EA, Webb WL, McDowall JM, et al. A field-based approach to support improved diabetes care in rural states. Prev Chronic Dis. 2005 Oct;2(4):A08. [PMC free article] [PubMed] [Google Scholar]
- 42.Coon P, Zulkowski K. Adherence to American Diabetes Association standards of care by rural health care providers. Diabetes Care. 2002 Dec;25(12):2224–2229. doi: 10.2337/diacare.25.12.2224. [DOI] [PubMed] [Google Scholar]
- 43.Shea S, Weinstock RS, Teresi JA, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study. J Am Med Inform Assoc. 2009 Jul-Aug;16(4):446–456. doi: 10.1197/jamia.M3157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Chan L, Hart LG, Goodman DC. Geographic access to health care for rural Medicare beneficiaries. J Rural Health. 2006 Spring;22(2):140–146. doi: 10.1111/j.1748-0361.2006.00022.x. [DOI] [PubMed] [Google Scholar]